RxDoctor Payments Data

Megan Busch, MD

Family Medicine · Centerton, ARNPI 1003234105

Payments from drug & device makers

$10,077in general payments, 2019–2025

Across 614 payments — averaging $16.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • AstraZeneca$1K
  • GSK$1K
  • Pfizer$821
  • Amgen$811
  • Lilly USA, LLC$764
  • plus $4K from 31 others

What the payments were for

  • Food & beverage$10,069100%
  • Education$70%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,077 in reported general payments places this provider in the 90th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$80,887
Medicare patients
218
Services billed
2,671

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide74$100,580
EliquisApixaban87$78,818
MounjaroTirzepatide58$65,466
FarxigaDapagliflozin Propanediol57$58,930
Trelegy ElliptaFluticasone/Umeclidin/Vilanter49$55,980
JardianceEmpagliflozin42$54,328
TrulicityDulaglutide16$32,893
XareltoRivaroxaban41$32,537
JanuviaSitagliptin Phosphate28$27,098
Breo ElliptaFluticasone/Vilanterol44$22,311
Nucynta ErTapentadol Hcl11$21,790
QuliptaAtogepant15$20,579
LinzessLinaclotide15$19,682
KerendiaFinerenone15$18,421
MyrbetriqMirabegron22$15,103

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$651$100,58074 claims
Lilly USA, LLCMounjaro, Trulicity$764$98,35874 claims
PfizerEliquis$821$78,81887 claims
GSKTrelegy Ellipta, Breo Ellipta$1,037$78,29193 claims
AstraZenecaFarxiga, Symbicort$1,142$61,37968 claims
Boehringer IngelheimJardiance$262$54,32842 claims
AbbVieQulipta, Linzess, Synthroid$1,592$41,42346 claims
Johnson & JohnsonXarelto$91$32,53741 claims
MerckJanuvia$358$27,09828 claims
Collegium Pharmaceutical, Inc.Nucynta Er$42$21,79011 claims
BayerKerendia$432$18,42115 claims
Astellas Pharma US IncMyrbetriq$181$15,10322 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,347 family medicine providers in Arkansas.

Other family medicine in Centerton

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →